Top Markets
#1 Threshold Network Threshold Network +65.04%
#2 TENDIES TENDIES +64.30%
#3 Cash Cat Cash Cat +22.24%
#4 OSK OSK +15.86%
#5 Magma Finance Magma Finance +13.64%
#6 Ape and Pepe Ape and Pepe +13.59%
#7 Asteroid Shiba Asteroid Shiba +13.00%
#8 Falcon Finance Falcon Finance +12.81%
#9 Kite Kite +12.56%
#10 龙虾 (Lobster) 龙虾 (Lobster) +11.22%
Coin of the day
Threshold Network Threshold Network
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Classement en actions #17290
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Prix de l'action
$1.35
Dernière synchronisation: 2026-09-01
Capitalisation boursière
$249.21M
Changement (1 jour)
1.13%
Changement (1 an)
-22.70%
Pays
US
Échange Neumora Therapeutics, Inc. Common Stock (NMRA)

Catégorie

Healthcare
Le prix NMRA avec la capitalisation boursière de B
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
NMRA
$1.35
Capitalisation boursière de Neumora Therapeutics, Inc. Common Stock(NMRA)
Capitalisation boursière: $249.21M
En September 2026, Neumora Therapeutics, Inc. Common Stock a une capitalisation boursière de $249.21M. Cela fait de Neumora Therapeutics, Inc. Common Stock la 17290th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Neumora Therapeutics, Inc. Common Stock du 2023 au 2026
NMRA par rapport au top 5 des plus populaires stocks
Prix pour NMRA L’actif B La capitalisation boursière de B Résultats
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
$28,386.71 $249.21M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.260T +2,110,435.90%
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
$25,790.27 $249.21M
Apple Inc. Apple Inc.
AAPL
$4.779T +1,917,392.51%
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
$21,678.81 $249.21M
Alphabet Inc. Alphabet Inc.
GOOG
$4.017T +1,611,707.10%
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
$20,073.53 $249.21M
Microsoft Corporation Microsoft Corporation
MSFT
$3.719T +1,492,356.06%
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock
$14,757.00 $249.21M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.734T +1,097,074.78%